Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses

Burton, B. K.; Wiesman, C.; Paras, A.; Kim, K.; Katz, R.

Mol Genet Metab. 2009 May 12; 97(3):234-6


The transition to home infusion therapy is described in 11 patients with mucopolysaccharide (MPS) disorders initially treated with enzyme replacement therapy (ERT) in an out-patient infusion center. Home therapy was well tolerated with no infusion-related reactions (IRR) occurring in 671 patient-weeks of treatment. In addition, compliance with the weekly treatment regimen was improved in patients on home therapy.

Read More on PubMed